BODi Shakeology to Launch at The Vitamin Shoppe Nationwide This Year
BODi announced that its premium protein and superfood nutrition solution, Shakeology, will launch in The Vitamin Shoppe nationwide later this year. The launch into The Vitamin Shoppe, which has over 640 locations, builds on Shakeology's entry into retail, with the product launching soon in more than 80 Sprouts Farmers Market locations across the U.S., the company said. Through this retail partnership, Shakeology will be available at The Vitamin Shoppe locations across the U.S. in a convenient seven-serving bag format, priced at $34.99. The initial launch will include four flagship flavors: Chocolate Whey, Vanilla Whey, Chocolate Vegan, and Vanilla Vegan. "Shakeology has been a trusted nutrition solution for millions of people for almost two decades," said Carl Daikeler, co-founder and CEO of BODi. "Expanding into The Vitamin Shoppe allows us to reach an even broader audience at a time when more consumers are becoming more proactive about their health and longevity by prioritizing high-quality nutrition. This is another important step in our goal to make Shakeology more accessible to more people."
Trade with 70% Backtested Accuracy
Analyst Views on BODI
About BODI
About the author

- Strong Earnings Outlook: A total of 836 companies are set to report earnings next week, with The Beachbody Company (BODI) and Deutsche Telekom (DTEGY) leading the pack, indicating robust growth potential in consumer services and telecom sectors.
- Financial Sector Resilience: Companies like Intercorp Financial Services (IFS) and Credicorp (BAP) are expected to perform well in their upcoming earnings reports, highlighting the stability of diversified banking, which may attract more investor interest.
- Healthcare Sector Pressure: Healthcare stocks such as IceCure Medical (ICCM) and LENZ Therapeutics (LENZ) rank among the weakest, reflecting ongoing pressures in the sector that could impact investor confidence.
- Quant Rating System: Seeking Alpha's Quant Rating system evaluates stocks, with BODI achieving a score of 4.96, showcasing its strong performance in valuation, growth, and profitability, potentially drawing more investor attention.
- Earnings Release Schedule: Beachbody Company is set to release its Q1 2026 results on May 12, 2026, after U.S. market close, reflecting the company's commitment to transparency and investor communication.
- Conference Call Details: The company will host a conference call at 5:00 p.m. Eastern Time on the same day, providing a toll-free dial-in number (833) 461-5787, aimed at sharing financial results and addressing investor inquiries.
- Webcast Availability: The conference call will be available via live webcast on the company's investor relations website, ensuring global investors can access real-time information and enhancing interaction between the company and its investors.
- Historical Context: Since its inception, Beachbody has helped over 30 million people achieve their health goals, continuing to focus on providing effective fitness and nutrition solutions for busy individuals, which underscores its leadership in the health industry.
- Market Decline: Consumer services shares collectively fell by approximately 1.3% on Monday, indicating a weak trend in the sector that could undermine investor confidence and lead to capital outflows.
- WW International Leads Drop: WW International's stock plummeted by about 15.2%, a significant decline likely driven by market concerns over its future growth prospects, prompting investors to reassess its investment value.
- Beachbody Also Affected: Beachbody's shares decreased by around 3.1%, reflecting a potential weakening in consumer demand for fitness and health products, which could adversely impact its sales and profitability.
- Uncertain Industry Outlook: The overall decline in the consumer services sector may signal signs of economic slowdown, necessitating investors to monitor future market dynamics to adjust their investment strategies.
- Stock Surge: The Beachbody Company (BODI) saw its shares rally 6.1% to close at $11.52, with notable trading volume indicating strong market confidence in its future performance.
- Profitability Improvement: The company is expected to report a quarterly loss of $0.02 per share, reflecting a 97.6% year-over-year improvement, suggesting a turnaround in profitability that may attract more investor interest.
- Revenue Expectations: Projected revenues of $52.24 million represent a 27.8% decline from the previous year; however, a robust innovation pipeline and retail expansion continue to support growth momentum, demonstrating the company's adaptability in the market.
- Analyst Ratings: BODI currently holds a Zacks Rank of 1 (Strong Buy), with a 44.4% upward revision in EPS estimates over the last 30 days, typically indicating potential stock price appreciation, prompting investors to closely monitor its future performance.
- Market Volatility Context: The market experienced fluctuations this week due to rising oil prices amid escalating uncertainty in the Middle East, causing investor concerns about the potential impact of high oil prices on economic growth; however, signs of market resilience are emerging as stocks begin to rebound.
- Allstate Earnings Outlook: Allstate's expected EPS growth rate for the next three to five years is 19%, significantly higher than the industry average of 7.7%, with a 7.5% upward revision in earnings estimates over the past 60 days, indicating strong financial performance potential.
- Five Below Growth Momentum: Five Below's stock surged 200.1% over the past year, with a projected earnings growth rate of 17.5% for fiscal 2027, and a 16.2% increase in earnings estimates over the past 60 days, reflecting robust performance in the retail sector.
- BrightSpring Health Services: BrightSpring's earnings growth estimate for 2026 stands at an impressive 61%, with a market capitalization of $8.4 billion and a 15% upward revision in earnings estimates over the past 60 days, showcasing significant growth potential in the healthcare services sector.
- Stock Surge: Beachbody (BODI) shares soared 33.3% to $11.10 on Wednesday afternoon, with over 183,000 shares traded, nearly four times the three-month average, reflecting strong market enthusiasm for the company's new retail strategy.
- Retail Strategy Shift: Starting in Q2, the company plans to offer its P90X and Shakeology supplements at grocery stores, drugstores, and club stores, which is expected to yield 'healthy margins', marking a significant shift towards nutrition products and a projected increase in revenue share by the end of 2026.
- Improved Financial Performance: Despite a 35.7% year-over-year revenue decline to $55.5 million, the company achieved a $64.1 million reduction in expenses in Q4, with gross margin rising from 70.5% to 74.5%, demonstrating effective cost control and enhanced profitability.
- User Growth Trend: Although total subscriptions dipped slightly to 950,000, the daily/monthly average users increased by 60 basis points to 31.3%, indicating a positive growth trend in user retention and engagement despite the overall decline in subscriptions.











